

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * detection of visible light (GO:0009584) | 9.81405406 |
| 2 | * visual perception (GO:0007601) | 8.60221542 |
| 3 | * sensory perception of light stimulus (GO:0050953) | 8.50327374 |
| 4 | retinal rod cell development (GO:0046548) | 8.42887571 |
| 5 | eye photoreceptor cell differentiation (GO:0001754) | 8.05660886 |
| 6 | photoreceptor cell differentiation (GO:0046530) | 8.05660886 |
| 7 | protein-chromophore linkage (GO:0018298) | 7.59126698 |
| 8 | * cellular response to light stimulus (GO:0071482) | 7.57037692 |
| 9 | * positive regulation of guanylate cyclase activity (GO:0031284) | 7.47625443 |
| 10 | * detection of external stimulus (GO:0009581) | 7.02046890 |
| 11 | retina development in camera-type eye (GO:0060041) | 6.89635468 |
| 12 | * detection of abiotic stimulus (GO:0009582) | 6.88986152 |
| 13 | * regulation of guanylate cyclase activity (GO:0031282) | 6.66866247 |
| 14 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 6.37504425 |
| 15 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.83884593 |
| 16 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 5.81410983 |
| 17 | * regulation of cGMP metabolic process (GO:0030823) | 5.49037750 |
| 18 | nonmotile primary cilium assembly (GO:0035058) | 5.40837779 |
| 19 | positive regulation of protein homooligomerization (GO:0032464) | 5.35183742 |
| 20 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.31040807 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.24418304 |
| 22 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.96567137 |
| 23 | * cellular response to radiation (GO:0071478) | 4.89445301 |
| 24 | short-term memory (GO:0007614) | 4.67195236 |
| 25 | prenylation (GO:0097354) | 4.65020334 |
| 26 | protein prenylation (GO:0018342) | 4.65020334 |
| 27 | regulation of penile erection (GO:0060405) | 4.61193887 |
| 28 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.48521599 |
| 29 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.48521599 |
| 30 | * regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.47011877 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.46808959 |
| 32 | retina homeostasis (GO:0001895) | 4.43991966 |
| 33 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 4.38948018 |
| 34 | adaptation of signaling pathway (GO:0023058) | 4.24285267 |
| 35 | * positive regulation of cGMP biosynthetic process (GO:0030828) | 4.19794212 |
| 36 | behavioral response to ethanol (GO:0048149) | 4.16938967 |
| 37 | chemosensory behavior (GO:0007635) | 4.06015041 |
| 38 | response to histamine (GO:0034776) | 4.03595559 |
| 39 | * sensory perception (GO:0007600) | 4.02429481 |
| 40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.01208614 |
| 41 | modulation by symbiont of host immune response (GO:0052553) | 4.01208614 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 4.01208614 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 4.01208614 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.01208614 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.01208614 |
| 46 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.99234789 |
| 47 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.99012040 |
| 48 | * regulation of cGMP biosynthetic process (GO:0030826) | 3.91572993 |
| 49 | * response to light stimulus (GO:0009416) | 3.84762418 |
| 50 | cellular response to virus (GO:0098586) | 3.82678367 |
| 51 | neuron development (GO:0048666) | 3.73948854 |
| 52 | regulation of histone H3-K27 methylation (GO:0061085) | 3.72599525 |
| 53 | tachykinin receptor signaling pathway (GO:0007217) | 3.71174927 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.69987109 |
| 55 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.69576102 |
| 56 | * positive regulation of cGMP metabolic process (GO:0030825) | 3.64873269 |
| 57 | regulation of protein homooligomerization (GO:0032462) | 3.63348608 |
| 58 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.62940833 |
| 59 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.60031638 |
| 60 | negative regulation of necroptotic process (GO:0060546) | 3.59837893 |
| 61 | macrophage activation involved in immune response (GO:0002281) | 3.59252450 |
| 62 | positive T cell selection (GO:0043368) | 3.52724033 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 3.48863976 |
| 64 | positive thymic T cell selection (GO:0045059) | 3.44029613 |
| 65 | B cell homeostasis (GO:0001782) | 3.42796210 |
| 66 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 3.42581329 |
| 67 | protein localization to synapse (GO:0035418) | 3.40912190 |
| 68 | protein heterotetramerization (GO:0051290) | 3.40530345 |
| 69 | histone H3 deacetylation (GO:0070932) | 3.40268713 |
| 70 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.39082260 |
| 71 | icosanoid secretion (GO:0032309) | 3.36466812 |
| 72 | arachidonic acid secretion (GO:0050482) | 3.36466812 |
| 73 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.35900811 |
| 74 | positive regulation of neurotransmitter transport (GO:0051590) | 3.35199238 |
| 75 | behavioral response to cocaine (GO:0048148) | 3.34653339 |
| 76 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.32689038 |
| 77 | synaptic transmission, dopaminergic (GO:0001963) | 3.32256248 |
| 78 | nuclear pore complex assembly (GO:0051292) | 3.28161107 |
| 79 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.26305621 |
| 80 | negative regulation of cation channel activity (GO:2001258) | 3.24491697 |
| 81 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.22026811 |
| 82 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.22026811 |
| 83 | B cell receptor signaling pathway (GO:0050853) | 3.20558967 |
| 84 | retina layer formation (GO:0010842) | 3.18882364 |
| 85 | negative regulation of cell killing (GO:0031342) | 3.18258942 |
| 86 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.18258942 |
| 87 | regulation of necroptotic process (GO:0060544) | 3.16135598 |
| 88 | regulation of neurotransmitter uptake (GO:0051580) | 3.08622190 |
| 89 | regulation of mast cell degranulation (GO:0043304) | 3.08399128 |
| 90 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 3.07691813 |
| 91 | membrane tubulation (GO:0097320) | 3.02764322 |
| 92 | dopamine receptor signaling pathway (GO:0007212) | 3.01847520 |
| 93 | dosage compensation (GO:0007549) | 3.01486766 |
| 94 | T cell selection (GO:0045058) | 3.00691187 |
| 95 | membrane hyperpolarization (GO:0060081) | 3.00289512 |
| 96 | histone H4 deacetylation (GO:0070933) | 2.99841728 |
| 97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.99423282 |
| 98 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.96959504 |
| 99 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.96959504 |
| 100 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.96895414 |
| 101 | modulation by virus of host process (GO:0019054) | 2.96703853 |
| 102 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.94661782 |
| 103 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.92778809 |
| 104 | regulation of germinal center formation (GO:0002634) | 2.92594978 |
| 105 | protein insertion into membrane (GO:0051205) | 2.91784914 |
| 106 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.91281187 |
| 107 | layer formation in cerebral cortex (GO:0021819) | 2.90843883 |
| 108 | positive regulation of interferon-alpha production (GO:0032727) | 2.89986646 |
| 109 | retinol metabolic process (GO:0042572) | 2.89857963 |
| 110 | regulation of dopamine metabolic process (GO:0042053) | 2.87963804 |
| 111 | regulation of catecholamine metabolic process (GO:0042069) | 2.87963804 |
| 112 | thymic T cell selection (GO:0045061) | 2.87275197 |
| 113 | neutrophil activation involved in immune response (GO:0002283) | 2.84862136 |
| 114 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.82126762 |
| 115 | erythrocyte development (GO:0048821) | 2.79019741 |
| 116 | mitochondrial fusion (GO:0008053) | 2.77853403 |
| 117 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.76867300 |
| 118 | estrogen biosynthetic process (GO:0006703) | 2.76207457 |
| 119 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75579533 |
| 120 | response to host immune response (GO:0052572) | 2.75579533 |
| 121 | sensory perception of smell (GO:0007608) | 2.74989387 |
| 122 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.74797155 |
| 123 | leukocyte aggregation (GO:0070486) | 2.74509974 |
| 124 | icosanoid transport (GO:0071715) | 2.73485952 |
| 125 | fatty acid derivative transport (GO:1901571) | 2.73485952 |
| 126 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.71864871 |
| 127 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.71680012 |
| 128 | response to host (GO:0075136) | 2.71680012 |
| 129 | response to host defenses (GO:0052200) | 2.71680012 |
| 130 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.71399478 |
| 131 | regulation of interferon-alpha production (GO:0032647) | 2.70694966 |
| 132 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.70346036 |
| 133 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.69941789 |
| 134 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.69881246 |
| 135 | modulation by symbiont of host cellular process (GO:0044068) | 2.69861104 |
| 136 | * response to radiation (GO:0009314) | 2.69440137 |
| 137 | positive regulation of protein oligomerization (GO:0032461) | 2.69149742 |
| 138 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.68362518 |
| 139 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.67668450 |
| 140 | regulation of B cell differentiation (GO:0045577) | 2.67443521 |
| 141 | negative regulation of necrotic cell death (GO:0060547) | 2.66172519 |
| 142 | activated T cell proliferation (GO:0050798) | 2.65954221 |
| 143 | head development (GO:0060322) | 2.65518063 |
| 144 | response to muramyl dipeptide (GO:0032495) | 2.65286591 |
| 145 | negative regulation of telomere maintenance (GO:0032205) | 2.64735551 |
| 146 | negative regulation of histone methylation (GO:0031061) | 2.64541025 |
| 147 | synaptic vesicle endocytosis (GO:0048488) | 2.64363024 |
| 148 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.63725260 |
| 149 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.63725260 |
| 150 | establishment of mitochondrion localization (GO:0051654) | 2.61766522 |
| 151 | positive regulation of membrane potential (GO:0045838) | 2.61282132 |
| 152 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.60244579 |
| 153 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.58661637 |
| 154 | germinal center formation (GO:0002467) | 2.58376287 |
| 155 | retinoid metabolic process (GO:0001523) | 2.57910664 |
| 156 | positive regulation of T cell cytokine production (GO:0002726) | 2.57352059 |
| 157 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.56957640 |
| 158 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.56941488 |
| 159 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.56597121 |
| 160 | regulation of leukocyte degranulation (GO:0043300) | 2.55886074 |
| 161 | peptidyl-arginine methylation (GO:0018216) | 2.54753969 |
| 162 | peptidyl-arginine N-methylation (GO:0035246) | 2.54753969 |
| 163 | regulation of gamma-delta T cell activation (GO:0046643) | 2.54429439 |
| 164 | sensory perception of chemical stimulus (GO:0007606) | 2.54020569 |
| 165 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.53974721 |
| 166 | cellular response to interleukin-4 (GO:0071353) | 2.53432263 |
| 167 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.52861419 |
| 168 | striatum development (GO:0021756) | 2.52494667 |
| 169 | tolerance induction (GO:0002507) | 2.52397634 |
| 170 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.51391827 |
| 171 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.51391827 |
| 172 | neutrophil activation (GO:0042119) | 2.51375920 |
| 173 | melanosome transport (GO:0032402) | 2.51328799 |
| 174 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.50922144 |
| 175 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.50901463 |
| 176 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.50429789 |
| 177 | mitochondrial calcium ion transport (GO:0006851) | 2.49786102 |
| 178 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.49285425 |
| 179 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.48571940 |
| 180 | lipid translocation (GO:0034204) | 2.47836829 |
| 181 | phospholipid translocation (GO:0045332) | 2.47836829 |
| 182 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.46728290 |
| 183 | cellular response to electrical stimulus (GO:0071257) | 2.45627380 |
| 184 | * cellular response to abiotic stimulus (GO:0071214) | 2.44070286 |
| 185 | sensory perception of taste (GO:0050909) | 2.41288816 |
| 186 | establishment of melanosome localization (GO:0032401) | 2.41247703 |
| 187 | diterpenoid metabolic process (GO:0016101) | 2.37662402 |
| 188 | cellular response to leptin stimulus (GO:0044320) | 2.37473984 |
| 189 | * regulation of rhodopsin mediated signaling pathway (GO:0022400) | 19.3284768 |
| 190 | * rhodopsin mediated signaling pathway (GO:0016056) | 18.6937649 |
| 191 | retinal cone cell development (GO:0046549) | 15.9822737 |
| 192 | photoreceptor cell development (GO:0042461) | 12.8049353 |
| 193 | eye photoreceptor cell development (GO:0042462) | 12.3320268 |
| 194 | photoreceptor cell maintenance (GO:0045494) | 12.0504422 |
| 195 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.4741104 |
| 196 | detection of light stimulus involved in visual perception (GO:0050908) | 11.4741104 |
| 197 | GMP metabolic process (GO:0046037) | 11.2134093 |
| 198 | * phototransduction (GO:0007602) | 10.6078735 |
| 199 | * phototransduction, visible light (GO:0007603) | 10.2675153 |
| 200 | * detection of light stimulus (GO:0009583) | 10.1231846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.10014980 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 4.86735239 |
| 3 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 4.62482634 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 4.06040230 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.51632549 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.47553796 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.46771605 |
| 8 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.26325879 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.98754157 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.76953684 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.52007910 |
| 12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.41447394 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.31714969 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.28272617 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.22974271 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.22459229 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.15998752 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.13176996 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11451963 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.04532239 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.03933767 |
| 22 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.98312012 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 1.98135185 |
| 24 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.98006598 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.93464996 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.91027851 |
| 27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.87041892 |
| 28 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.86288075 |
| 29 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.86090644 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83650247 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.82976098 |
| 32 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.81251206 |
| 33 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.80735477 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.76891481 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75344218 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72104619 |
| 37 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.71267076 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70071417 |
| 39 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.68306820 |
| 40 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.67723729 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66506846 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66467875 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.66396900 |
| 44 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.63458170 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.62877644 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61902810 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60230153 |
| 48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.59611306 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59380149 |
| 50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58231762 |
| 51 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56333276 |
| 52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.55336685 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55098299 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54778993 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53539008 |
| 56 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.53047926 |
| 57 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.51323624 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.50859801 |
| 59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49171673 |
| 60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47325339 |
| 61 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.47077032 |
| 62 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.46531922 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46279265 |
| 64 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46107330 |
| 65 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45819276 |
| 66 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.45641656 |
| 67 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.45380162 |
| 68 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.43790488 |
| 69 | MYB_26560356_Chip-Seq_TH1_Human | 1.43574645 |
| 70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41686503 |
| 71 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41444114 |
| 72 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.41296053 |
| 73 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.40791885 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40636180 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40603209 |
| 76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.40406973 |
| 77 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.39727944 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39346547 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39143377 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.37572939 |
| 81 | AR_19668381_ChIP-Seq_PC3_Human | 1.37087801 |
| 82 | NCOR_22424771_ChIP-Seq_293T_Human | 1.34811831 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32635628 |
| 84 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.31788572 |
| 85 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.29034947 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26951221 |
| 87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26773354 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26640321 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26218249 |
| 90 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.26026908 |
| 91 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.25710321 |
| 92 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.25097394 |
| 93 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24844750 |
| 94 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.24684448 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23898713 |
| 96 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23348993 |
| 97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.22900386 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22508151 |
| 99 | MYB_26560356_Chip-Seq_TH2_Human | 1.21498461 |
| 100 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.20710954 |
| 101 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.19885687 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19549418 |
| 103 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19123585 |
| 104 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.18327617 |
| 105 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18296513 |
| 106 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18241761 |
| 107 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17184844 |
| 108 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16690224 |
| 109 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15839313 |
| 110 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15723535 |
| 111 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14540201 |
| 112 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.14413211 |
| 113 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12658319 |
| 114 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12339357 |
| 115 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11827451 |
| 116 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.11817632 |
| 117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11793085 |
| 118 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11514481 |
| 119 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.10791399 |
| 120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10538015 |
| 121 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09648657 |
| 122 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08988502 |
| 123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08838647 |
| 124 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08507638 |
| 125 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.07713478 |
| 126 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.07713478 |
| 127 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07565416 |
| 128 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.07384619 |
| 129 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06909866 |
| 130 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.06780780 |
| 131 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06502844 |
| 132 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06372915 |
| 133 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05276267 |
| 134 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.05180591 |
| 135 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04036849 |
| 136 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03634543 |
| 137 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03087450 |
| 138 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02641746 |
| 139 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.01913034 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01796041 |
| 141 | TBL1_22424771_ChIP-Seq_293T_Human | 1.01737262 |
| 142 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01704438 |
| 143 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01546778 |
| 144 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00948663 |
| 145 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.00900885 |
| 146 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.00882420 |
| 147 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00550421 |
| 148 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99929647 |
| 149 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99623642 |
| 150 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99534449 |
| 151 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.98681557 |
| 152 | ATF3_27146783_Chip-Seq_COLON_Human | 0.98608893 |
| 153 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.98413740 |
| 154 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97189641 |
| 155 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97126348 |
| 156 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.97041447 |
| 157 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96828225 |
| 158 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96294898 |
| 159 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96174802 |
| 160 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.95968366 |
| 161 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95499679 |
| 162 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.95345452 |
| 163 | * P68_20966046_ChIP-Seq_HELA_Human | 0.95092791 |
| 164 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.94750431 |
| 165 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.94609996 |
| 166 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94058560 |
| 167 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.93461567 |
| 168 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.92826983 |
| 169 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92654015 |
| 170 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92274229 |
| 171 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92037678 |
| 172 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91485975 |
| 173 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91425627 |
| 174 | CBP_21632823_ChIP-Seq_H3396_Human | 0.91166609 |
| 175 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.89228097 |
| 176 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.88751884 |
| 177 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88070547 |
| 178 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87374710 |
| 179 | ERA_21632823_ChIP-Seq_H3396_Human | 0.87251670 |
| 180 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.86972201 |
| 181 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86614492 |
| 182 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85725571 |
| 183 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.84955717 |
| 184 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.84810052 |
| 185 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.84287581 |
| 186 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84212141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005551_abnormal_eye_electrophysiolog | 9.76520817 |
| 2 | MP0005253_abnormal_eye_physiology | 7.03325497 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.34954272 |
| 4 | MP0003950_abnormal_plasma_membrane | 4.77916080 |
| 5 | MP0005451_abnormal_body_composition | 4.28994744 |
| 6 | MP0005195_abnormal_posterior_eye | 3.90265266 |
| 7 | MP0001986_abnormal_taste_sensitivity | 3.60914663 |
| 8 | MP0002638_abnormal_pupillary_reflex | 3.49916584 |
| 9 | MP0003436_decreased_susceptibility_to | 3.47456251 |
| 10 | MP0001324_abnormal_eye_pigmentation | 3.42182228 |
| 11 | MP0005423_abnormal_somatic_nervous | 3.36472589 |
| 12 | MP0005391_vision/eye_phenotype | 3.36036961 |
| 13 | MP0008260_abnormal_autophagy | 2.77459277 |
| 14 | MP0003221_abnormal_cardiomyocyte_apopto | 2.69308402 |
| 15 | MP0009840_abnormal_foam_cell | 2.54526997 |
| 16 | MP0002090_abnormal_vision | 2.52180594 |
| 17 | MP0001764_abnormal_homeostasis | 2.46611448 |
| 18 | MP0005083_abnormal_biliary_tract | 2.46485317 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.45933902 |
| 20 | MP0002229_neurodegeneration | 2.43502823 |
| 21 | MP0003303_peritoneal_inflammation | 2.39265260 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.22181806 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.13624695 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 2.10509036 |
| 25 | MP0003011_delayed_dark_adaptation | 10.3661191 |
| 26 | MP0009278_abnormal_bone_marrow | 1.94711647 |
| 27 | MP0002752_abnormal_somatic_nervous | 1.89779855 |
| 28 | MP0002102_abnormal_ear_morphology | 1.87575794 |
| 29 | MP0001800_abnormal_humoral_immune | 1.84727876 |
| 30 | MP0005671_abnormal_response_to | 1.78107944 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.73897082 |
| 32 | MP0002419_abnormal_innate_immunity | 1.72134175 |
| 33 | MP0002398_abnormal_bone_marrow | 1.71202537 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.63635623 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.62112064 |
| 36 | MP0001819_abnormal_immune_cell | 1.58507742 |
| 37 | MP0000747_muscle_weakness | 1.57370502 |
| 38 | MP0005025_abnormal_response_to | 1.56641614 |
| 39 | MP0002723_abnormal_immune_serum | 1.56169017 |
| 40 | MP0004510_myositis | 1.56077048 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.55279482 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.48337215 |
| 43 | MP0001348_abnormal_lacrimal_gland | 1.46045291 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.43469262 |
| 45 | MP0000716_abnormal_immune_system | 1.43211714 |
| 46 | MP0009785_altered_susceptibility_to | 1.42342148 |
| 47 | MP0008007_abnormal_cellular_replicative | 1.39365224 |
| 48 | MP0005387_immune_system_phenotype | 1.36626523 |
| 49 | MP0001790_abnormal_immune_system | 1.36626523 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.34844170 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.33648732 |
| 52 | MP0002722_abnormal_immune_system | 1.32955140 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.30429422 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.30429422 |
| 55 | MP0004947_skin_inflammation | 1.30303310 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.28042772 |
| 57 | MP0002429_abnormal_blood_cell | 1.27948372 |
| 58 | MP0008874_decreased_physiological_sensi | 1.27900670 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.27605664 |
| 60 | MP0001835_abnormal_antigen_presentation | 1.27118019 |
| 61 | MP0000858_altered_metastatic_potential | 1.23254516 |
| 62 | MP0004019_abnormal_vitamin_homeostasis | 1.22537756 |
| 63 | MP0001984_abnormal_olfaction | 1.20371028 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.16449721 |
| 65 | MP0005197_abnormal_uvea_morphology | 1.15222247 |
| 66 | MP0002127_abnormal_cardiovascular_syste | 1.13879225 |
| 67 | MP0002132_abnormal_respiratory_system | 1.11239527 |
| 68 | MP0000678_abnormal_parathyroid_gland | 1.06960229 |
| 69 | MP0002405_respiratory_system_inflammati | 1.06554000 |
| 70 | MP0003828_pulmonary_edema | 1.05150959 |
| 71 | MP0006035_abnormal_mitochondrial_morpho | 1.03864620 |
| 72 | MP0003329_amyloid_beta_deposits | 1.02419752 |
| 73 | MP0000685_abnormal_immune_system | 1.02085617 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.01996228 |
| 75 | MP0000313_abnormal_cell_death | 0.99714107 |
| 76 | MP0002089_abnormal_postnatal_growth/wei | 0.99386614 |
| 77 | MP0004858_abnormal_nervous_system | 0.98942065 |
| 78 | MP0004087_abnormal_muscle_fiber | 0.98132827 |
| 79 | MP0004233_abnormal_muscle_weight | 0.97617208 |
| 80 | MP0002332_abnormal_exercise_endurance | 0.97403156 |
| 81 | MP0003111_abnormal_nucleus_morphology | 0.96901344 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 0.96638856 |
| 83 | MP0004185_abnormal_adipocyte_glucose | 0.96506346 |
| 84 | MP0005187_abnormal_penis_morphology | 0.96241389 |
| 85 | MP0010630_abnormal_cardiac_muscle | 0.95013334 |
| 86 | MP0001845_abnormal_inflammatory_respons | 0.93569197 |
| 87 | MP0004885_abnormal_endolymph | 0.93035190 |
| 88 | MP0009115_abnormal_fat_cell | 0.90015950 |
| 89 | MP0005394_taste/olfaction_phenotype | 0.89190757 |
| 90 | MP0005499_abnormal_olfactory_system | 0.89190757 |
| 91 | MP0003724_increased_susceptibility_to | 0.88530696 |
| 92 | MP0000609_abnormal_liver_physiology | 0.88170604 |
| 93 | MP0006138_congestive_heart_failure | 0.86257668 |
| 94 | MP0003690_abnormal_glial_cell | 0.83162553 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.82898909 |
| 96 | MP0002272_abnormal_nervous_system | 0.82083939 |
| 97 | MP0002653_abnormal_ependyma_morphology | 0.81985045 |
| 98 | MP0004197_abnormal_fetal_growth/weight/ | 0.81853330 |
| 99 | MP0008789_abnormal_olfactory_epithelium | 0.81765251 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.80886600 |
| 101 | MP0001502_abnormal_circadian_rhythm | 0.80293695 |
| 102 | MP0000604_amyloidosis | 0.78889268 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.78446762 |
| 104 | MP0003634_abnormal_glial_cell | 0.78058314 |
| 105 | MP0002877_abnormal_melanocyte_morpholog | 0.76742563 |
| 106 | MP0000759_abnormal_skeletal_muscle | 0.75371379 |
| 107 | MP0003693_abnormal_embryo_hatching | 0.74524712 |
| 108 | MP0008995_early_reproductive_senescence | 0.74298802 |
| 109 | MP0000598_abnormal_liver_morphology | 0.73257578 |
| 110 | MP0008469_abnormal_protein_level | 0.71615078 |
| 111 | MP0002269_muscular_atrophy | 0.69451071 |
| 112 | MP0005621_abnormal_cell_physiology | 0.67530328 |
| 113 | MP0002106_abnormal_muscle_physiology | 0.66828625 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.66597743 |
| 115 | MP0003959_abnormal_lean_body | 0.64549013 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.58314137 |
| 117 | MP0004270_analgesia | 0.56468132 |
| 118 | MP0006292_abnormal_olfactory_placode | 0.56286887 |
| 119 | MP0001486_abnormal_startle_reflex | 0.55638303 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.52268647 |
| 121 | MP0002734_abnormal_mechanical_nocicepti | 0.48582374 |
| 122 | MP0001963_abnormal_hearing_physiology | 0.48179392 |
| 123 | MP0004145_abnormal_muscle_electrophysio | 0.46278865 |
| 124 | MP0009046_muscle_twitch | 0.45824575 |
| 125 | MP0001286_abnormal_eye_development | 0.44948067 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.43365466 |
| 127 | MP0008058_abnormal_DNA_repair | 0.43355843 |
| 128 | MP0003646_muscle_fatigue | 0.42396502 |
| 129 | MP0003045_fibrosis | 0.41784009 |
| 130 | MP0002064_seizures | 0.40306688 |
| 131 | MP0003880_abnormal_central_pattern | 0.40039589 |
| 132 | MP0001905_abnormal_dopamine_level | 0.38316457 |
| 133 | MP0004085_abnormal_heartbeat | 0.35992966 |
| 134 | MP0004142_abnormal_muscle_tone | 0.35980153 |
| 135 | MP0005620_abnormal_muscle_contractility | 0.34632043 |
| 136 | MP0002067_abnormal_sensory_capabilities | 0.34339314 |
| 137 | MP0004215_abnormal_myocardial_fiber | 0.33818128 |
| 138 | MP0002572_abnormal_emotion/affect_behav | 0.32835960 |
| 139 | MP0001661_extended_life_span | 0.32792065 |
| 140 | MP0000026_abnormal_inner_ear | 0.32376648 |
| 141 | MP0003635_abnormal_synaptic_transmissio | 0.31047757 |
| 142 | MP0004859_abnormal_synaptic_plasticity | 0.30508886 |
| 143 | MP0003638_abnormal_response/metabolism_ | 0.29630686 |
| 144 | MP0002063_abnormal_learning/memory/cond | 0.29291069 |
| 145 | MP0005084_abnormal_gallbladder_morpholo | 0.29177141 |
| 146 | MP0003252_abnormal_bile_duct | 0.28943823 |
| 147 | MP0000465_gastrointestinal_hemorrhage | 0.27966286 |
| 148 | MP0004043_abnormal_pH_regulation | 0.27628905 |
| 149 | MP0005076_abnormal_cell_differentiation | 0.27500723 |
| 150 | MP0009745_abnormal_behavioral_response | 0.27136989 |
| 151 | MP0002928_abnormal_bile_duct | 0.27103542 |
| 152 | MP0005646_abnormal_pituitary_gland | 0.24211728 |
| 153 | MP0000631_abnormal_neuroendocrine_gland | 0.23886160 |
| 154 | MP0000767_abnormal_smooth_muscle | 0.23297802 |
| 155 | MP0000751_myopathy | 0.23149797 |
| 156 | MP0002108_abnormal_muscle_morphology | 0.22602704 |
| 157 | MP0001968_abnormal_touch/_nociception | 0.20979651 |
| 158 | MP0000230_abnormal_systemic_arterial | 0.20915981 |
| 159 | MP0005310_abnormal_salivary_gland | 0.20892851 |
| 160 | MP0001188_hyperpigmentation | 0.19988426 |
| 161 | MP0003943_abnormal_hepatobiliary_system | 0.19581296 |
| 162 | MP0004924_abnormal_behavior | 0.19060621 |
| 163 | MP0005386_behavior/neurological_phenoty | 0.19060621 |
| 164 | MP0005193_abnormal_anterior_eye | 0.17282350 |
| 165 | MP0004811_abnormal_neuron_physiology | 0.16027492 |
| 166 | MP0002168_other_aberrant_phenotype | 0.15502949 |
| 167 | MP0001915_intracranial_hemorrhage | 0.13923537 |
| 168 | MP0008569_lethality_at_weaning | 0.13920342 |
| 169 | MP0002066_abnormal_motor_capabilities/c | 0.13836218 |
| 170 | MP0005330_cardiomyopathy | 0.13146769 |
| 171 | MP0005266_abnormal_metabolism | 0.13001288 |
| 172 | MP0001501_abnormal_sleep_pattern | 0.12319817 |
| 173 | MP0008004_abnormal_stomach_pH | 0.11658415 |
| 174 | MP0002152_abnormal_brain_morphology | 0.11259765 |
| 175 | MP0000749_muscle_degeneration | 0.10293365 |
| 176 | MP0005319_abnormal_enzyme/_coenzyme | 0.09887811 |
| 177 | MP0003632_abnormal_nervous_system | 0.09369084 |
| 178 | MP0001177_atelectasis | 0.08709913 |
| 179 | MP0001614_abnormal_blood_vessel | 0.08535812 |
| 180 | MP0009780_abnormal_chondrocyte_physiolo | 0.07928195 |
| 181 | MP0000001_mammalian_phenotype | 0.07868849 |
| 182 | MP0005365_abnormal_bile_salt | 0.07651372 |
| 183 | MP0009764_decreased_sensitivity_to | 0.07520841 |
| 184 | MP0002184_abnormal_innervation | 0.07246977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 9.86544227 |
| 2 | Chorioretinal atrophy (HP:0000533) | 9.37145856 |
| 3 | Attenuation of retinal blood vessels (HP:0007843) | 8.33224517 |
| 4 | Pendular nystagmus (HP:0012043) | 7.44503421 |
| 5 | Central scotoma (HP:0000603) | 7.20512975 |
| 6 | Abnormality of macular pigmentation (HP:0008002) | 6.77512722 |
| 7 | Dyschromatopsia (HP:0007641) | 6.47212901 |
| 8 | Scotoma (HP:0000575) | 6.47002011 |
| 9 | Decreased central vision (HP:0007663) | 6.06766131 |
| 10 | Abolished electroretinogram (ERG) (HP:0000550) | 5.70437353 |
| 11 | * Type II diabetes mellitus (HP:0005978) | 5.68555437 |
| 12 | * Photophobia (HP:0000613) | 5.55584477 |
| 13 | Keratoconus (HP:0000563) | 5.02417070 |
| 14 | Increased corneal curvature (HP:0100692) | 5.02417070 |
| 15 | Retinitis pigmentosa (HP:0000510) | 4.87587034 |
| 16 | Macular degeneration (HP:0000608) | 4.67363410 |
| 17 | Vitreoretinal degeneration (HP:0000655) | 4.65808446 |
| 18 | Choroideremia (HP:0001139) | 4.64603897 |
| 19 | Cone-rod dystrophy (HP:0000548) | 4.41276266 |
| 20 | Peripheral hypomyelination (HP:0007182) | 4.32557847 |
| 21 | Hemorrhage of the eye (HP:0011885) | 4.03248193 |
| 22 | Ulnar claw (HP:0001178) | 3.99954391 |
| 23 | Severe visual impairment (HP:0001141) | 3.91491989 |
| 24 | Reticulocytosis (HP:0001923) | 3.69533160 |
| 25 | Constricted visual fields (HP:0001133) | 3.60628017 |
| 26 | Progressive inability to walk (HP:0002505) | 3.60367842 |
| 27 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.60000606 |
| 28 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.57593830 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.50933432 |
| 30 | Progressive external ophthalmoplegia (HP:0000590) | 3.45262637 |
| 31 | Increased IgE level (HP:0003212) | 3.23883589 |
| 32 | Posterior subcapsular cataract (HP:0007787) | 3.18893997 |
| 33 | Poikiloderma (HP:0001029) | 3.10884752 |
| 34 | Abnormality of macrophages (HP:0004311) | 3.07703459 |
| 35 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.05341568 |
| 36 | Gait imbalance (HP:0002141) | 2.97433264 |
| 37 | Agammaglobulinemia (HP:0004432) | 2.96316149 |
| 38 | Congenital primary aphakia (HP:0007707) | 2.95427766 |
| 39 | Progressive visual loss (HP:0000529) | 2.92169514 |
| 40 | Optic disc pallor (HP:0000543) | 2.92167548 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 2.89033189 |
| 42 | Episodic fever (HP:0001954) | 2.88794632 |
| 43 | Decreased motor nerve conduction velocity (HP:0003431) | 2.81529201 |
| 44 | Foot dorsiflexor weakness (HP:0009027) | 2.74306635 |
| 45 | Polycythemia (HP:0001901) | 2.71707681 |
| 46 | Onion bulb formation (HP:0003383) | 2.70927294 |
| 47 | Retinal atrophy (HP:0001105) | 2.69703258 |
| 48 | Abnormality of the foot musculature (HP:0001436) | 2.69669187 |
| 49 | Deep venous thrombosis (HP:0002625) | 2.69247547 |
| 50 | Exercise-induced myalgia (HP:0003738) | 2.68466860 |
| 51 | Steppage gait (HP:0003376) | 2.65500327 |
| 52 | Cellulitis (HP:0100658) | 2.64049872 |
| 53 | Nephrogenic diabetes insipidus (HP:0009806) | 2.63393979 |
| 54 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.62019153 |
| 55 | Papilloma (HP:0012740) | 2.59507849 |
| 56 | Verrucae (HP:0200043) | 2.59507849 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.55759392 |
| 58 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.55659638 |
| 59 | Increased variability in muscle fiber diameter (HP:0003557) | 2.54846331 |
| 60 | * Wide nasal bridge (HP:0000431) | 2.53837265 |
| 61 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.39754938 |
| 62 | Subaortic stenosis (HP:0001682) | 2.39754938 |
| 63 | Abnormality of the peritoneum (HP:0002585) | 2.38896420 |
| 64 | Myopathic facies (HP:0002058) | 2.38355546 |
| 65 | Hammertoe (HP:0001765) | 2.35397576 |
| 66 | Poikilocytosis (HP:0004447) | 2.34773723 |
| 67 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.34724401 |
| 68 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.33370946 |
| 69 | Gastrointestinal stroma tumor (HP:0100723) | 2.31972508 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.30803033 |
| 71 | Abnormality of the vocal cords (HP:0008777) | 2.30151646 |
| 72 | Neuronal loss in central nervous system (HP:0002529) | 2.29850050 |
| 73 | Basal cell carcinoma (HP:0002671) | 2.28560579 |
| 74 | Poor coordination (HP:0002370) | 2.27476248 |
| 75 | Supranuclear gaze palsy (HP:0000605) | 2.22257486 |
| 76 | Osteomyelitis (HP:0002754) | 2.20842920 |
| 77 | Meningitis (HP:0001287) | 2.19807875 |
| 78 | Abnormality of the fingertips (HP:0001211) | 2.19778997 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.14991968 |
| 80 | Bowel incontinence (HP:0002607) | 2.12541289 |
| 81 | Fatigue (HP:0012378) | 2.12163871 |
| 82 | Ragged-red muscle fibers (HP:0003200) | 2.11893481 |
| 83 | Panhypogammaglobulinemia (HP:0003139) | 2.09761166 |
| 84 | Acute hepatic failure (HP:0006554) | 2.09616160 |
| 85 | Orchitis (HP:0100796) | 2.09127918 |
| 86 | Rapidly progressive (HP:0003678) | 2.09044993 |
| 87 | Recurrent abscess formation (HP:0002722) | 2.08241197 |
| 88 | Pelvic girdle muscle weakness (HP:0003749) | 2.06823631 |
| 89 | Myositis (HP:0100614) | 2.05226266 |
| 90 | Increased serum ferritin (HP:0003281) | 2.04091173 |
| 91 | Vaginal atresia (HP:0000148) | 2.03257046 |
| 92 | Obstructive lung disease (HP:0006536) | 2.03039111 |
| 93 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03039111 |
| 94 | Thin bony cortex (HP:0002753) | 2.02642884 |
| 95 | Recurrent pneumonia (HP:0006532) | 2.02592156 |
| 96 | Recurrent fungal infections (HP:0002841) | 2.02042394 |
| 97 | Resting tremor (HP:0002322) | 2.01960879 |
| 98 | Colitis (HP:0002583) | 2.01001652 |
| 99 | Nonimmune hydrops fetalis (HP:0001790) | 2.00376083 |
| 100 | Impaired pain sensation (HP:0007328) | 2.00201578 |
| 101 | Abnormality of pain sensation (HP:0010832) | 2.00201578 |
| 102 | Congenital stationary night blindness (HP:0007642) | 17.9061188 |
| 103 | Bony spicule pigmentary retinopathy (HP:0007737) | 12.2278120 |
| 104 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.4582894 |
| 105 | Pigmentary retinal degeneration (HP:0001146) | 10.1959294 |
| 106 | Dysmetric saccades (HP:0000641) | 1.99444435 |
| 107 | Abnormal hair whorl (HP:0010721) | 1.98910376 |
| 108 | Mutism (HP:0002300) | 1.97211914 |
| 109 | Cerebral palsy (HP:0100021) | 1.96402843 |
| 110 | Joint hemorrhage (HP:0005261) | 1.94048577 |
| 111 | Genital tract atresia (HP:0001827) | 1.93917797 |
| 112 | Broad face (HP:0000283) | 1.92927235 |
| 113 | Congenital sensorineural hearing impairment (HP:0008527) | 1.92914861 |
| 114 | EMG: neuropathic changes (HP:0003445) | 1.92823237 |
| 115 | Distal lower limb amyotrophy (HP:0008944) | 1.91378990 |
| 116 | Deep palmar crease (HP:0006191) | 1.91128300 |
| 117 | Recurrent viral infections (HP:0004429) | 1.90823447 |
| 118 | Neonatal respiratory distress (HP:0002643) | 1.89642121 |
| 119 | Abnormal large intestine physiology (HP:0012700) | 1.87563997 |
| 120 | Viral hepatitis (HP:0006562) | 1.87192835 |
| 121 | Abnormal platelet function (HP:0011869) | 1.86956754 |
| 122 | Impaired platelet aggregation (HP:0003540) | 1.86956754 |
| 123 | Subcapsular cataract (HP:0000523) | 1.85386589 |
| 124 | Cortical dysplasia (HP:0002539) | 1.84357774 |
| 125 | Amblyopia (HP:0000646) | 1.84128540 |
| 126 | Retrobulbar optic neuritis (HP:0100654) | 1.82736725 |
| 127 | Optic neuritis (HP:0100653) | 1.82736725 |
| 128 | Distal sensory impairment (HP:0002936) | 1.82648212 |
| 129 | Termporal pattern (HP:0011008) | 1.80437082 |
| 130 | Insidious onset (HP:0003587) | 1.80437082 |
| 131 | Sepsis (HP:0100806) | 1.80019139 |
| 132 | True hermaphroditism (HP:0010459) | 1.79796248 |
| 133 | Peritonitis (HP:0002586) | 1.77999297 |
| 134 | Birth length less than 3rd percentile (HP:0003561) | 1.77559361 |
| 135 | Abnormality of reticulocytes (HP:0004312) | 1.74467308 |
| 136 | Hypochromic anemia (HP:0001931) | 1.71973073 |
| 137 | * Optic atrophy (HP:0000648) | 1.65681803 |
| 138 | Interstitial pulmonary disease (HP:0006530) | 1.64880217 |
| 139 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.62199605 |
| 140 | Cerebellar dysplasia (HP:0007033) | 1.40928456 |
| 141 | Broad foot (HP:0001769) | 1.27838800 |
| 142 | Dysdiadochokinesis (HP:0002075) | 1.27016107 |
| 143 | Astigmatism (HP:0000483) | 1.22712034 |
| 144 | Decreased testicular size (HP:0008734) | 1.21344864 |
| 145 | Left ventricular hypertrophy (HP:0001712) | 1.20721266 |
| 146 | Specific learning disability (HP:0001328) | 1.18844016 |
| 147 | Horizontal nystagmus (HP:0000666) | 1.18188621 |
| 148 | Pancreatic fibrosis (HP:0100732) | 1.17088811 |
| 149 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.16121709 |
| 150 | Hypoplasia of the fovea (HP:0007750) | 1.16121709 |
| 151 | Abnormality of the fovea (HP:0000493) | 1.13221857 |
| 152 | Retinal detachment (HP:0000541) | 1.10214259 |
| 153 | Asthma (HP:0002099) | 1.09728759 |
| 154 | Severe Myopia (HP:0011003) | 1.08369496 |
| 155 | Recurrent sinusitis (HP:0011108) | 1.06837182 |
| 156 | Partial agenesis of the corpus callosum (HP:0001338) | 1.05349685 |
| 157 | Epileptic encephalopathy (HP:0200134) | 1.03017759 |
| 158 | Cystic liver disease (HP:0006706) | 0.99054640 |
| 159 | Polar cataract (HP:0010696) | 0.96528357 |
| 160 | Pancreatic cysts (HP:0001737) | 0.92185158 |
| 161 | Febrile seizures (HP:0002373) | 0.90869295 |
| 162 | Abnormal sex determination (HP:0012244) | 0.90237170 |
| 163 | Sex reversal (HP:0012245) | 0.90237170 |
| 164 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.84945922 |
| 165 | Dental crowding (HP:0000678) | 0.84496857 |
| 166 | Truncal ataxia (HP:0002078) | 0.84194891 |
| 167 | Abnormality of dental color (HP:0011073) | 0.83788723 |
| 168 | Osteomalacia (HP:0002749) | 0.82771932 |
| 169 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.81283578 |
| 170 | Hypodontia (HP:0000668) | 0.80110751 |
| 171 | Progressive cerebellar ataxia (HP:0002073) | 0.78659683 |
| 172 | Chorioretinal coloboma (HP:0000567) | 0.78145183 |
| 173 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.76588217 |
| 174 | Short foot (HP:0001773) | 0.76117848 |
| 175 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.75557266 |
| 176 | Heterotopia (HP:0002282) | 0.72266878 |
| 177 | Polycystic ovaries (HP:0000147) | 0.72226407 |
| 178 | Hypermetropia (HP:0000540) | 0.72187016 |
| 179 | Postaxial hand polydactyly (HP:0001162) | 0.70977050 |
| 180 | Cholecystitis (HP:0001082) | 0.69509391 |
| 181 | Abnormal gallbladder physiology (HP:0012438) | 0.69509391 |
| 182 | Nephrotic syndrome (HP:0000100) | 0.68986560 |
| 183 | Abnormality of midbrain morphology (HP:0002418) | 0.68311543 |
| 184 | Molar tooth sign on MRI (HP:0002419) | 0.68311543 |
| 185 | Lymphopenia (HP:0001888) | 0.67702428 |
| 186 | Chronic hepatic failure (HP:0100626) | 0.67003073 |
| 187 | Hirsutism (HP:0001007) | 0.66919620 |
| 188 | Furrowed tongue (HP:0000221) | 0.66579644 |
| 189 | Sclerocornea (HP:0000647) | 0.65067710 |
| 190 | Visual hallucinations (HP:0002367) | 0.62269422 |
| 191 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.61026571 |
| 192 | Multicystic kidney dysplasia (HP:0000003) | 0.58496523 |
| 193 | Nephronophthisis (HP:0000090) | 0.58433287 |
| 194 | Prominent nasal bridge (HP:0000426) | 0.58416817 |
| 195 | Congenital hepatic fibrosis (HP:0002612) | 0.56055525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK1 | 9.26204611 |
| 2 | ERN1 | 3.89387014 |
| 3 | SIK3 | 3.88977107 |
| 4 | CCNB1 | 3.39684336 |
| 5 | EEF2K | 3.35223999 |
| 6 | RIPK4 | 2.77752647 |
| 7 | PRPF4B | 2.61921890 |
| 8 | MAP3K11 | 2.51596117 |
| 9 | MAP4K1 | 2.44568749 |
| 10 | IRAK2 | 2.38449965 |
| 11 | INSRR | 2.34971757 |
| 12 | EPHB1 | 2.20577383 |
| 13 | TRIB3 | 2.16985369 |
| 14 | PINK1 | 2.14372009 |
| 15 | PBK | 10.3040996 |
| 16 | KSR1 | 1.98540288 |
| 17 | TAOK3 | 1.94117222 |
| 18 | RPS6KA4 | 1.80959906 |
| 19 | KSR2 | 1.77830110 |
| 20 | TYK2 | 1.69687728 |
| 21 | MAPK7 | 1.69678523 |
| 22 | MAP3K13 | 1.65561685 |
| 23 | SIK1 | 1.64674476 |
| 24 | ADRBK1 | 1.61676100 |
| 25 | MAP2K3 | 1.56962846 |
| 26 | MAP3K1 | 1.53565552 |
| 27 | MAP3K12 | 1.52296228 |
| 28 | ZAP70 | 1.41623312 |
| 29 | SMG1 | 1.30962265 |
| 30 | IRAK4 | 1.30493787 |
| 31 | MAP2K4 | 1.30244082 |
| 32 | PRKCZ | 1.28169355 |
| 33 | ICK | 1.25197394 |
| 34 | SIK2 | 1.23544343 |
| 35 | IRAK3 | 1.18363491 |
| 36 | TBK1 | 1.18018686 |
| 37 | CDK3 | 1.16825500 |
| 38 | MAPK12 | 1.15280991 |
| 39 | BCR | 1.11472949 |
| 40 | SGK223 | 1.07328916 |
| 41 | SGK494 | 1.07328916 |
| 42 | MARK2 | 1.05824492 |
| 43 | CAMK1G | 1.05615986 |
| 44 | BLK | 1.03638108 |
| 45 | NEK6 | 1.02338891 |
| 46 | RIPK1 | 1.00609829 |
| 47 | CSK | 0.99267001 |
| 48 | MAP3K14 | 0.99070876 |
| 49 | CLK1 | 0.98399578 |
| 50 | AKT3 | 0.95843304 |
| 51 | CAMK1D | 0.94363137 |
| 52 | TYRO3 | 0.92430124 |
| 53 | MARK1 | 0.90917820 |
| 54 | IKBKE | 0.89691827 |
| 55 | PRKD3 | 0.88055006 |
| 56 | MKNK2 | 0.87759948 |
| 57 | NEK1 | 0.87145558 |
| 58 | BRD4 | 0.86217127 |
| 59 | FGFR4 | 0.85578300 |
| 60 | STK38 | 0.84485847 |
| 61 | MARK3 | 0.84300554 |
| 62 | JAK2 | 0.81931731 |
| 63 | CSNK1D | 0.81201703 |
| 64 | SGK2 | 0.80483279 |
| 65 | MAP3K5 | 0.79350844 |
| 66 | PDK1 | 0.78847874 |
| 67 | BMX | 0.77867207 |
| 68 | NEK2 | 0.77297937 |
| 69 | HCK | 0.77123144 |
| 70 | ALK | 0.76868236 |
| 71 | MINK1 | 0.74928321 |
| 72 | TRIM28 | 0.74925678 |
| 73 | DYRK3 | 0.74768364 |
| 74 | HIPK2 | 0.72040197 |
| 75 | TTK | 0.71987483 |
| 76 | CSNK1A1L | 0.71975030 |
| 77 | MAPK11 | 0.71934949 |
| 78 | PHKG2 | 0.71563469 |
| 79 | PHKG1 | 0.71563469 |
| 80 | PRKCH | 0.68645848 |
| 81 | CDK12 | 0.68447575 |
| 82 | MOS | 0.67681208 |
| 83 | SYK | 0.67437818 |
| 84 | PDPK1 | 0.66742708 |
| 85 | PRKACG | 0.66619723 |
| 86 | PRKAA1 | 0.65545196 |
| 87 | CAMKK1 | 0.65233190 |
| 88 | SGK3 | 0.64756313 |
| 89 | TTN | 0.63552168 |
| 90 | MAP3K10 | 0.61529135 |
| 91 | PAK6 | 0.61356271 |
| 92 | GRK6 | 0.58214519 |
| 93 | RPS6KA5 | 0.57578272 |
| 94 | JAK1 | 0.57551843 |
| 95 | RPS6KB2 | 0.57154815 |
| 96 | MATK | 0.57055283 |
| 97 | MTOR | 0.56391169 |
| 98 | DYRK1A | 0.55988565 |
| 99 | MAP3K3 | 0.55671160 |
| 100 | BTK | 0.54995046 |
| 101 | STK10 | 0.54929825 |
| 102 | CDK4 | 0.54776903 |
| 103 | FES | 0.54240260 |
| 104 | PRKCB | 0.54040864 |
| 105 | TAOK2 | 0.53819943 |
| 106 | TESK2 | 0.53028951 |
| 107 | PNCK | 0.52609075 |
| 108 | CAMK1 | 0.51778599 |
| 109 | WNK1 | 0.51635183 |
| 110 | CAMK2D | 0.51089924 |
| 111 | GRK5 | 0.50910790 |
| 112 | CAMK2A | 0.50031581 |
| 113 | MYLK | 0.49954637 |
| 114 | PASK | 0.48770725 |
| 115 | MAP2K6 | 0.48575246 |
| 116 | PDGFRB | 0.47832268 |
| 117 | RPS6KA3 | 0.47700927 |
| 118 | MAPK13 | 0.47201729 |
| 119 | PDK2 | 0.45688764 |
| 120 | PRKCG | 0.45653194 |
| 121 | TGFBR2 | 0.45001098 |
| 122 | PRKAA2 | 0.44871214 |
| 123 | LCK | 0.43607637 |
| 124 | CDK18 | 0.43409959 |
| 125 | MAPK15 | 0.42138334 |
| 126 | PKN2 | 0.41845376 |
| 127 | ERBB2 | 0.41279475 |
| 128 | PIM1 | 0.40825174 |
| 129 | AKT2 | 0.40511739 |
| 130 | CASK | 0.39859498 |
| 131 | CDK14 | 0.39732969 |
| 132 | PLK2 | 0.39319554 |
| 133 | MAP3K4 | 0.39292352 |
| 134 | CSF1R | 0.37430460 |
| 135 | FGR | 0.36970606 |
| 136 | MAPKAPK2 | 0.36624421 |
| 137 | CDK15 | 0.36425286 |
| 138 | PRKDC | 0.36233046 |
| 139 | CHEK2 | 0.34293066 |
| 140 | SGK1 | 0.32591880 |
| 141 | RPS6KB1 | 0.31976587 |
| 142 | PRKACA | 0.31960892 |
| 143 | MAPK9 | 0.31293143 |
| 144 | PRKD2 | 0.31250752 |
| 145 | GSK3B | 0.28605449 |
| 146 | PRKCA | 0.28373396 |
| 147 | MAPK14 | 0.27480785 |
| 148 | CAMK4 | 0.27379711 |
| 149 | MKNK1 | 0.26541473 |
| 150 | YES1 | 0.26320695 |
| 151 | PLK3 | 0.25895389 |
| 152 | MAPK3 | 0.21408034 |
| 153 | CHUK | 0.20149703 |
| 154 | MAPK10 | 0.20007965 |
| 155 | CDK5 | 0.19033436 |
| 156 | SCYL2 | 0.18860424 |
| 157 | STK11 | 0.18230105 |
| 158 | CDK1 | 0.16900626 |
| 159 | NTRK3 | 0.16320817 |
| 160 | MAP3K7 | 0.15967610 |
| 161 | PKN1 | 0.15218639 |
| 162 | IRAK1 | 0.12719418 |
| 163 | TNK2 | 0.12549655 |
| 164 | CHEK1 | 0.12324400 |
| 165 | MAP2K7 | 0.11966178 |
| 166 | PRKCI | 0.10023718 |
| 167 | CSNK1E | 0.09125319 |
| 168 | MAPK8 | 0.08549674 |
| 169 | SRC | 0.08270608 |
| 170 | CDK9 | 0.07770152 |
| 171 | CDC42BPA | 0.07521226 |
| 172 | DYRK1B | 0.07471982 |
| 173 | ATM | 0.07385615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.28078245 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.24178622 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.15721466 |
| 4 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.14033551 |
| 5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.05020994 |
| 6 | * Phototransduction_Homo sapiens_hsa04744 | 16.1919489 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.92785215 |
| 8 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.78074273 |
| 9 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.76565400 |
| 10 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.75894133 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61724110 |
| 12 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.58227510 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54404816 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.52622724 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51655168 |
| 16 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.51319490 |
| 17 | Hepatitis B_Homo sapiens_hsa05161 | 1.46870784 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45002109 |
| 19 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.44896701 |
| 20 | Olfactory transduction_Homo sapiens_hsa04740 | 1.43530281 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40957668 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36377415 |
| 23 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.30854411 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30705300 |
| 25 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.29031513 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26661400 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.25573041 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.24343657 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23542665 |
| 30 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.20027627 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.17195671 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.17090089 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17077426 |
| 34 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.14741317 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.14499860 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.11766793 |
| 37 | GABAergic synapse_Homo sapiens_hsa04727 | 1.08301194 |
| 38 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.08169959 |
| 39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.07606500 |
| 40 | Colorectal cancer_Homo sapiens_hsa05210 | 1.05886556 |
| 41 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05467407 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04678329 |
| 43 | Endocytosis_Homo sapiens_hsa04144 | 1.00013498 |
| 44 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.98906351 |
| 45 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.97943359 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96773166 |
| 47 | Thyroid cancer_Homo sapiens_hsa05216 | 0.92950335 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90975217 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90100152 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89601220 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86425078 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86363937 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.85728461 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82444530 |
| 55 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.81281090 |
| 56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80214483 |
| 57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.78882445 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78811128 |
| 59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76374668 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75836685 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 0.75751733 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73833357 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72445632 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 0.72122623 |
| 65 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.71520915 |
| 66 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70544392 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70286810 |
| 68 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.65373796 |
| 69 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.65199557 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.64840244 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64062524 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.62470351 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61424789 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.61266370 |
| 75 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60069375 |
| 76 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59949563 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59841485 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59374757 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.55476723 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.55451574 |
| 81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54731907 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49514462 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49442645 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49364274 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47044469 |
| 86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46571615 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.46010463 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45242883 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45049310 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.45028468 |
| 91 | Purine metabolism_Homo sapiens_hsa00230 | 0.44470515 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.44342696 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.44148921 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43908294 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43137986 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42958726 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41768625 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39745213 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.34562360 |
| 100 | Nicotine addiction_Homo sapiens_hsa05033 | 0.34322192 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33927239 |
| 102 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33876517 |
| 103 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.32680637 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32666702 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32519312 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31095534 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30575027 |
| 108 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29465720 |
| 109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.28444130 |
| 110 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.27940354 |
| 111 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27938538 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27502805 |
| 113 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27334212 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25534634 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.25151315 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.24040607 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.22457693 |
| 118 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.22120580 |
| 119 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.21463366 |
| 120 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.21248100 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20793561 |
| 122 | Renin secretion_Homo sapiens_hsa04924 | 0.19578181 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19362154 |
| 124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.19189571 |
| 125 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19103159 |
| 126 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18484498 |
| 127 | Alcoholism_Homo sapiens_hsa05034 | 0.17612223 |
| 128 | Salivary secretion_Homo sapiens_hsa04970 | 0.16540735 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15729971 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15668248 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15538492 |
| 132 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.15030256 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14310670 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.14235393 |
| 135 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.13640057 |
| 136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.13027200 |
| 137 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.12900169 |
| 138 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.11565110 |
| 139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11258502 |
| 140 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.11005991 |
| 141 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.09982911 |
| 142 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.09238361 |
| 143 | Lysine degradation_Homo sapiens_hsa00310 | 0.08805095 |
| 144 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.08599716 |
| 145 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.08212903 |
| 146 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.07838074 |
| 147 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.07667970 |
| 148 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.06986830 |
| 149 | Long-term potentiation_Homo sapiens_hsa04720 | 0.06570434 |
| 150 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.06364794 |
| 151 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.05991495 |
| 152 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.05675005 |
| 153 | Carbon metabolism_Homo sapiens_hsa01200 | 0.05617557 |
| 154 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.05599903 |
| 155 | Bile secretion_Homo sapiens_hsa04976 | 0.05199486 |
| 156 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.05116459 |
| 157 | Taste transduction_Homo sapiens_hsa04742 | 0.04921061 |
| 158 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.04545877 |
| 159 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.04216189 |
| 160 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.04029274 |
| 161 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.04023217 |
| 162 | Base excision repair_Homo sapiens_hsa03410 | 0.03509541 |
| 163 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.03407221 |
| 164 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.03287601 |
| 165 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.03205911 |
| 166 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.02961411 |
| 167 | RNA degradation_Homo sapiens_hsa03018 | 0.02701011 |
| 168 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.02446927 |
| 169 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.02382498 |
| 170 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.02292299 |
| 171 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.01683447 |
| 172 | Insulin resistance_Homo sapiens_hsa04931 | 0.01644543 |
| 173 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.01295755 |
| 174 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.01157950 |

